Axsome Therapeutics to Participate in Upcoming Investor Conferences
(NasdaqGM:AXSM), NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in three upcoming investor conferences in June: William Blair 45th Annual Growth Stock ConferenceThe Company will present on Tuesday, […]